General Surgery Coding Alert - 2005 Issue 27
MEDICARE DRUG BENEFIT: CMS Demanding Extensive Formularies From PDPs
Subscribe or sign in to view the full article.
Article Overview
This article explains CMS guidance on Part D formulary design and the requirement that sponsors include broad coverage in certain therapeutic categories. It covers the agency’s stated rationale, concerns raised by plan sponsors and the Academy of Managed Care Pharmacy, and the broader implications for Medicare prescription drug benefit participation. It is relevant to Medicare Part D stakeholders, health plans, PBMs, and compliance professionals reviewing formulary expectations.
Why This Topic Matters
The article addresses a policy issue that affects how prescription drug plans structure coverage under Medicare Part D and how sponsors assess participation, cost control, and compliance. It helps readers understand the types of formulary guidance being applied by CMS and the concerns that such guidance may create for plan design.
What You Will Learn
- What CMS guidance says about formulary expectations for Part D plans
- Why some sponsors view the guidance as challenging for plan design and cost control
- How the Academy of Managed Care Pharmacy responded to the CMS position
- The general policy rationale CMS gives for broader drug access in certain categories
Who Should Read This
- Medicare Part D prescription drug plan sponsors
- Health plans
- Pharmacy benefit managers
- Managed care pharmacy professionals
- Healthcare compliance and policy analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com